Patents by Inventor Mai-Britt Zocca

Mai-Britt Zocca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOTHERAPEUTIC TARGETING OF PLACENTAL-LIKE CHONDROITIN SULFATE USING CHIMERIC ANTIGEN RECEPTORS (CARS) AND IMMUNOTHERAPEUTIC TARGETING OF CANCER USING CARS WITH SPLIT-PROTEIN BINDING SYSTEMS
    Publication number: 20180298098
    Abstract: The present invention relates to polypeptides comprising conditionally active chimeric antigen receptor (CAR) and a split-protein binding system, a VAR2CSA polypeptide, or any other targeting agent. The present invention further relates to poly-peptides comprising VAR2CSA polypeptides or other targeting agent, and a split-protein binding system.
    Type: Application
    Filed: February 26, 2016
    Publication date: October 18, 2018
    Applicant: VAR2 Pharmaceutical ApS
    Inventor: Mai-Britt Zocca
  • MICRO RNAS AS MARKERS OF THE FUNCTIONAL STATE OF A DENDRITIC CELL
    Publication number: 20100266555
    Abstract: The present invention relates to the use of specified micro RNAs as markers of the functional state of a dendritic cell. In one aspect the invention relates to a method for producing a quality-controlled therapeutic composition comprising dendritic cells. In another aspect the invention relates to a method of in vitro screening of immunomodulatory compounds.
    Type: Application
    Filed: November 14, 2008
    Publication date: October 21, 2010
    Applicants: DANDRIT BIOTECH A/S, BIONEER A/S
    Inventors: Simon Skjøde Jensen, Kim Holmstrøm, Ayako Wakatsuki Pedersen, Mai-Britt Zocca
  • METHOD FOR GENERATING TOLEROGENIC DENDRITIC CELLS EMPLOYING DECREASED TEMPERATURE
    Publication number: 20100233197
    Abstract: The invention relates in certain embodiments to a method for generating tolerogenic dendritic cells by employing temperatures below 37° C. and phenotype-modifying agents during the development of progenitor cells and immature dendritic cells. In some embodiments the invention relates to populations of dendritic cells and their use.
    Type: Application
    Filed: November 13, 2008
    Publication date: September 16, 2010
    Applicant: DANDRIT BIOTECH A/S
    Inventors: Ayako Wakatsuki Pedersen, Mai-Britt Zocca